Đang chuẩn bị liên kết để tải về tài liệu:
Skeletal muscle loss during neoadjuvant chemotherapy predicts poor prognosis in patients with breast cancer

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

The skeletal muscle index (SMI), which is calculated as the ratio of skeletal muscle area at the third lumbar vertebral level divided by height squared, has been considered a prognostic factor in patients with breast cancer. |

TÀI LIỆU LIÊN QUAN

An in vitro human skeletal muscle model: Coculture of myotubes, neuron-like cells and the capillary network

Gender-specific associations between low skeletal muscle mass and albuminuria in the middle-aged and elderly population

RaceRunning training improves stamina and promotes skeletal muscle hypertrophy in young individuals with cerebral palsy

Effect of peripheral blood mononuclear cells on induced ischemia/reperfusion in skeletal muscle of adult male albino rat: An immunohistochemical study

Comprehensive analysis of differentially expressed circRNAs and ceRNA regulatory network in porcine skeletal muscle

Trend analysis of the role of circular RNA in goat skeletal muscle development

Skeletal muscle in aged mice reveals extensive transformation of muscle gene expression

Preoperative nutritional risk index and postoperative one-year skeletal muscle loss can predict the prognosis of patients with gastric adenocarcinoma: A registry-based study

Intermittent whole-body vibration attenuates a reduction in the number of the capillaries in unloaded rat skeletal muscle

Pulmonary inflammation-induced alterations in key regulators of mitophagy and mitochondrial biogenesis in murine skeletal muscle